Figure Gallery

Expression Pattern Search Results for runx1

(401 figures with expression from 192 publications)

[ Show only figures with images ]
Publication	Data	Fish	Condition	Stage Range	Anatomy
Bresciani et al., 2014	Fig. 5	WT cbfb^hg10/hg10 cbfb^hg11/hg11	standard conditions	Long-pec to Protruding-mouth	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 7	WT kca3Tg; kca4Tg	control heat shock	Prim-25	dorsal aorta posterior cardinal vein ventral wall of dorsal aorta
Carroll et al., 2014	Fig. 4	nc2aTg kca3Tg; kca4Tg	control chemical treatment by environment: DAPT, chemical treatment by environment: 17beta-estradiol heat shock chemical treatment by environment: 17beta-estradiol chemical treatment by environment: DAPT heat shock, chemical treatment by environment: DAPT, chemical treatment by environment: 17beta-estradiol heat shock, chemical treatment by environment: 17beta-estradiol heat shock, chemical treatment by environment: DAPT	Prim-25	ventral wall of dorsal aorta
	Fig. 7	WT kdrl^y17/y17 plcg1^y13/y13	control chemical treatment by environment: estrogen receptor antagonist chemical treatment by environment: 17beta-estradiol	Prim-15 to Prim-25	posterior cardinal vein ventral wall of dorsal aorta whole organism
	Fig. 2	WT WT + MO1-esr2a WT + MO1-esr2b WT + MO2-esr1 WT + MO1-esr2a + MO1-esr2b	control chemical treatment by environment: 17beta-estradiol	Prim-25	ventral wall of dorsal aorta
	Fig. 1	WT	control chemical treatment by environment: 17alpha-estradiol, chemical treatment by environment: fulvestrant chemical treatment by environment: 17beta-estradiol, chemical treatment by environment: fulvestrant chemical treatment by environment: 17beta-estradiol chemical treatment by environment: 17alpha-estradiol chemical treatment by environment: fulvestrant	Prim-25	ventral wall of dorsal aorta whole organism
	Fig. 3	WT	control chemical treatment by environment: 17beta-estradiol	Prim-25	ventral wall of dorsal aorta
	Fig. 5	WT	control chemical treatment by environment: bisphenol A, chemical treatment by environment: fulvestrant, chemical treatment by environment: DAPT chemical treatment by environment: fulvestrant, chemical treatment by environment: genistein chemical treatment by environment: 17alpha-ethynylestradiol, chemical treatment by environment: fulvestrant chemical treatment by environment: genistein chemical treatment by environment: 17alpha-ethynylestradiol chemical treatment by environment: bisphenol A chemical treatment by environment: fulvestrant	Prim-25	ventral wall of dorsal aorta whole organism
Chen et al., 2014	Fig. 1	WT WT + MO1-iqcg	standard conditions control	Prim-25	ventral wall of dorsal aorta
Espín-Palazón et al., 2014	Fig. 3	bw9Tg; kca3Tg kca3Tg; kca4Tg bw9Tg; kca3Tg + MO2-tnfrsf1b bw9Tg; kca3Tg + MO4-tnfa kca3Tg; kca4Tg + MO2-tnfrsf1b kca3Tg; kca4Tg + MO4-tnfa	standard conditions heat shock	Prim-5	ventral wall of dorsal aorta ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 4	WT WT + MO2-jag1a WT + MO2-tnfrsf1b WT + MO2-jag1a + MO2-tnfrsf1b	standard conditions	Prim-5	ventral wall of dorsal aorta ventral wall of dorsal aorta hematopoietic stem cell
Ge et al., 2014	Fig. 6	AB AB + MO1-tet2	standard conditions control	10-13 somites to Prim-25	dorsal aorta erythroid lineage cell
Hu et al., 2014	Fig. 2	AB AB + MO3-eaf1	standard conditions control	Prim-15 to Long-pec	hematopoietic stem cell ventral wall of dorsal aorta
Kim et al., 2014	Fig. 6	AB AB + MO2-dld AB + MO6-notch3 dlc^tit446/+ (AB) dlc^tit446/+ + MO6-notch3 (AB) AB + MO2-dld + MO6-notch3	standard conditions standard conditions standard conditions standard conditions	Prim-5	dorsal aorta hematopoietic multipotent progenitor cell dorsal aorta hematopoietic stem cell
	Fig. S4	AB AB + MO2-notch2 AB + MO5-notch1a AB + MO7-notch1b	standard conditions standard conditions standard conditions standard conditions	Prim-5	hematopoietic multipotent progenitor cell
	Fig. 7	AB AB + MO2-wnt16	standard conditions standard conditions	Prim-5	hematopoietic multipotent progenitor cell
	Fig. S5	AB notch1a^b420/b420 notch2^el517/el517 AB + MO6-notch1b AB + MO6-notch1b + MO6-notch3	standard conditions standard conditions standard conditions	Prim-5	hematopoietic multipotent progenitor cell
	Fig. 1	AB AB + MO6-notch3	standard conditions standard conditions	Prim-5	dorsal aorta hematopoietic multipotent progenitor cell dorsal aorta hematopoietic stem cell
	Fig. 4	AB	control chemical treatment: pharmaceutical	Prim-5	dorsal aorta hematopoietic multipotent progenitor cell dorsal aorta hematopoietic stem cell
	Fig. S1	AB notch3^fh332/fh332	standard conditions	Prim-5	hematopoietic multipotent progenitor cell
	Fig. S6	AB	standard conditions	Prim-5	hematopoietic multipotent progenitor cell
	Fig. 5	bw9Tg; kca3Tg hzm7Et; kca3Tg bw9Tg; kca3Tg + MO6-notch3 hzm7Et; kca3Tg + MO6-notch3	standard conditions standard conditions control heat shock heat shock	Prim-5	hematopoietic multipotent progenitor cell
	Fig. 3	kca3Tg; kca4Tg kca3Tg; kca4Tg + MO6-notch3	standard conditions standard conditions heat shock heat shock	Prim-5	hematopoietic multipotent progenitor cell
Kobayashi et al., 2014	Fig. S6	WT jam2a^{hu3319/hu3319}	standard conditions	Prim-5	dorsal aorta
	Fig. S7	kca3Tg; kca4Tg kca3Tg; ubs4Tg kca3Tg; kca4Tg + MO1-f11r.1 kca3Tg; kca4Tg + MO1-jam2a kca3Tg; ubs4Tg + MO1-f11r.1 kca3Tg; ubs4Tg + MO1-jam2a	standard conditions standard conditions standard conditions heat shock heat shock heat shock	Prim-5	dorsal aorta